These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28663807)

  • 1. R77Q and Q3R HIV1-VPR mutations in an otherwise asymptomatic 5-year-old child with repeated ear infections.
    Soares R; Rocha G; Nogueira C; Meliço-Silvestre A; Gonçalves T
    JMM Case Rep; 2014 Dec; 1(4):e002709. PubMed ID: 28663807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vpr and HIV-1 disease progression: R77Q mutation is associated with long-term control of HIV-1 infection in different groups of patients.
    Mologni D; Citterio P; Menzaghi B; Zanone Poma B; Riva C; Broggini V; Sinicco A; Milazzo L; Adorni F; Rusconi S; Galli M; Riva A;
    AIDS; 2006 Feb; 20(4):567-74. PubMed ID: 16470121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of R77Q, R77A and R80A changes in Vpr on HIV-1 replication and CD4 T cell depletion in human lymphoid tissue ex vivo.
    Rajan D; Wildum S; Rücker E; Schindler M; Kirchhoff F
    AIDS; 2006 Apr; 20(6):831-6. PubMed ID: 16549966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a cytopathogenicity determinant in HIV-1 Vpr.
    Somasundaran M; Sharkey M; Brichacek B; Luzuriaga K; Emerman M; Sullivan JL; Stevenson M
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9503-8. PubMed ID: 12093916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An HIV-1 infected long-term non-progressor (LTNP): molecular analysis of HIV-1 strains in the vpr and nef genes.
    Saksena NK; Ge YC; Wang B; Xiang SH; Dwyer DE; Randle C; Palasanthiran P; Ziegler J; Cunningham AL
    Ann Acad Med Singap; 1996 Nov; 25(6):848-54. PubMed ID: 9055015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the Vpr R77Q mutation associated with long-term non-progression of HIV infection?
    Fischer A; Lejczak C; Lambert C; Roman F; Servais J; Karita E; Allen S; Schmit JC; Arendt V
    AIDS; 2004 Jun; 18(9):1346-7. PubMed ID: 15362672
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene defects clustered at the C-terminus of the vpr gene of HIV-1 in long-term nonprogressing mother and child pair: in vivo evolution of vpr quasispecies in blood and plasma.
    Wang B; Ge YC; Palasanthiran P; Xiang SH; Ziegler J; Dwyer DE; Randle C; Dowton D; Cunningham A; Saksena NK
    Virology; 1996 Sep; 223(1):224-32. PubMed ID: 8806556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of two unique naturally occurring Vpr sequence polymorphisms associated with clinical parameters in HIV-1 chronic infection.
    Kamori D; Hasan Z; Ohashi J; Kawana-Tachikawa A; Gatanaga H; Oka S; Ueno T
    J Med Virol; 2017 Jan; 89(1):123-129. PubMed ID: 27328918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional conservation of HIV-1 Vpr and variability in a mother-child pair of long-term non-progressors.
    Zhao Y; Chen M; Wang B; Yang J; Elder RT; Song XQ; Yu M; Saksena NK
    Virus Res; 2002 Oct; 89(1):103-21. PubMed ID: 12367754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV1-viral protein R (Vpr) mutations: associated phenotypes and relevance for clinical pathologies.
    Soares R; Rocha G; Meliço-Silvestre A; Gonçalves T
    Rev Med Virol; 2016 Sep; 26(5):314-29. PubMed ID: 27264019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection.
    Zhang L; Huang Y; Yuan H; Tuttleton S; Ho DD
    Virology; 1997 Feb; 228(2):340-9. PubMed ID: 9123841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection.
    Rodés B; Toro C; Paxinos E; Poveda E; Martinez-Padial M; Benito JM; Jimenez V; Wrin T; Bassani S; Soriano V
    AIDS; 2004 May; 18(8):1109-16. PubMed ID: 15166526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT.
    Andersen JL; DeHart JL; Zimmerman ES; Ardon O; Kim B; Jacquot G; Benichou S; Planelles V
    PLoS Pathog; 2006 Dec; 2(12):e127. PubMed ID: 17140287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vpr in plasma of HIV type 1-positive patients is correlated with the HIV type 1 RNA titers.
    Hoshino S; Sun B; Konishi M; Shimura M; Segawa T; Hagiwara Y; Koyanagi Y; Iwamoto A; Mimaya J; Terunuma H; Kano S; Ishizaka Y
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):391-7. PubMed ID: 17411372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIVagm: genetic and biological features associated with replication.
    Müller MC; Barré-Sinoussi F
    Front Biosci; 2003 Sep; 8():d1170-85. PubMed ID: 12957815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of latent HIV-1 infection of resting CD4(+) T lymphocytes does not require inactivation of Vpr.
    Shen A; Siliciano JD; Pierson TC; Buck CB; Siliciano RF
    Virology; 2000 Dec; 278(1):227-33. PubMed ID: 11112497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.
    Hermankova M; Ray SC; Ruff C; Powell-Davis M; Ingersoll R; D'Aquila RT; Quinn TC; Siliciano JD; Siliciano RF; Persaud D
    JAMA; 2001 Jul; 286(2):196-207. PubMed ID: 11448283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells?
    Azad AA
    Biochem Biophys Res Commun; 2000 Jan; 267(3):677-85. PubMed ID: 10673351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation.
    Yao XJ; Subbramanian RA; Rougeau N; Boisvert F; Bergeron D; Cohen EA
    J Virol; 1995 Nov; 69(11):7032-44. PubMed ID: 7474123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutations.
    Fourati S; Malet I; Guenzel CA; Soulie C; Maidou-Peindara P; Morand-Joubert L; Wirden M; Sayon S; Peytavin G; Simon A; Katlama C; Benichou S; Calvez V; Marcelin AG
    Antiviral Res; 2012 Jan; 93(1):167-74. PubMed ID: 22138483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.